Home › Calculator › CTXR Dividend Calculator 2026
CTXR Dividend Calculator 2026
No dividendHealthcareCitius Pharmaceuticals, Inc. · NASDAQ
Price: $0.40 · Annual div: None · Frequency: — · Payout ratio: N/A · Ex-div: —
Calculator settings
CTXR is not a dividend-focused stock
CTXR pays a very low or no dividend (Yield: 0.00%). This calculator is designed for income-producing assets. If your goal is passive income and compounding, you might want to look at these popular alternatives:
Portfolio growth: DRIP vs No DRIP
Annual dividend income growth
CTXR Dividend Yield
Citius Pharmaceuticals, Inc. (CTXR) does not currently pay a regular dividend in our data, so its dividend yield is 0%.
💡 What-if scenarios
Click to apply scenario to the calculator
🎯 When CTXR pays your bills
Year your monthly dividend income covers each expense (based on current settings)
About Citius Pharmaceuticals, Inc. (CTXR) — Dividend Analysis 2026
Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products within its pipeline: Mino-Lok: An antibiotic lock solution designed to combat catheter-related bloodstream infections by salvaging the infected central venous catheter. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizing infections associated with tissue expanders following breast reconstructive procedures. Halo-Lido: A topical formulation that blends a corticosteroid with lidocaine, intended to deliver both anti-inflammatory and numbing relief to individuals suffering from hemorrhoids. NoveCite: A mesenchymal stem cell therapy currently under development for treating acute respiratory distress syndrome (ARDS). I/ONTAK: An engineered fusion protein, combining IL-2 and diphtheria toxin, purposed for the treatment of patients experiencing persistent or recurrent cutaneous T-cell lymphoma. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
CTXR Dividend & DRIP — Frequently Asked Questions
Does CTXR pay a dividend?
No. Citius Pharmaceuticals, Inc. (CTXR) has not paid a regular dividend in the last 12 months in our data, so its dividend yield is 0% and it produces no dividend income.
How can I get dividend income instead of CTXR?
Dividend ETFs such as SCHD, VYM or JEPI pay regular income. Open their DRIP calculators to see what $10,000 would earn per month and how reinvesting grows it.
Does CTXR have a DRIP (dividend reinvestment plan)?
A DRIP reinvests dividends into new shares. CTXR has no regular dividend in our data, so there is nothing to reinvest.
Stocks similar to CTXR
Forward dividend yield from the latest data · open any DRIP calculator
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
Get Your Full CTXR DRIP Report by Email
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. · Privacy Policy
Ready to invest? Open CTXR position with:
🌍 CTXR Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold CTXR.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| 🇺🇸 Roth IRA / 401k | 0% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (15%) ✓ | 15% | 0.00% | -2.80% | $0 / yr |
| 🇺🇸 US Taxable (20%) | 20% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK ISA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇬🇧 UK Taxable | 8.75% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 TFSA | 0% | 0.00% | -2.80% | $0 / yr |
| 🇨🇦 CA Taxable | 25% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 Super (pension) | 15% | 0.00% | -2.80% | $0 / yr |
| 🇦🇺 AU Taxable | 30% | 0.00% | -2.80% | $0 / yr |
| 🇩🇪 DE Taxable | 26.375% | 0.00% | -2.80% | $0 / yr |
| 🇫🇷 FR Taxable | 30% | 0.00% | -2.80% | $0 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 CTXR Income Goal & Break-Even
12-month CPI (US BLS via FMP economic-indicators).
No dividend data available for this ticker.
Based on current dividend of $0.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 CTXR Dividend Payment Schedule
CTXR pays quarterly — 4 times per year. Ex-div: —.
📊 CTXR vs Healthcare Benchmarks
How CTXR compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for CTXR sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ CTXR Insider Activity
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2025-08-08 | 125,490 | $28.75 | $3.61M | ||
| A-Award | 2025-08-08 | 89,388 | $19.25 | $1.72M | ||
| D-Return | 2025-08-08 | 125,490 | $28.75 | $3.61M | ||
| D-Return | 2025-08-08 | 89,388 | $19.25 | $1.72M | ||
| A-Award | 2025-08-08 | 31,373 | $28.75 | $902.0K | ||
| A-Award | 2025-08-08 | 22,344 | $19.25 | $430.1K | ||
| D-Return | 2025-08-08 | 22,344 | $19.25 | $430.1K | ||
| D-Return | 2025-08-08 | 31,373 | $28.75 | $902.0K | ||
| A-Award | 2024-11-07 | 125,000 | $0.38 | $47.5K | ||
| A-Award | 2024-11-07 | 125,000 | $0.38 | $47.5K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Peer Group
Similar companies in the same sectorCompare CTXR with peers: CTXR vs ADTX · CTXR vs APLM · CTXR vs ATHA
Financial Health Scores
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores → lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the CTXR dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →
Citius Pharmaceuticals, Inc. (CTXR) is currently trading at $0.40, 78% below its 52-week high. It does not currently pay a regular dividend.
Does CTXR Pay a Dividend? Citius Pharmaceuticals, Inc. Dividend Status
Citius Pharmaceuticals, Inc. (CTXR) is a healthcare stock trading at $0.40. It does not currently pay a regular dividend in our data, so it produces no dividend income and DRIP reinvestment does not apply. Investors seeking income often look at dividend ETFs such as SCHD, VYM or JEPI instead.
- Without a dividend, returns depend entirely on the share price.
Auto-generated from live market data. For educational purposes only — not financial advice.
Latest CTXR News
LiveProjected your CTXR DRIP returns?
If DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.